ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,072.02
-0.24%
Gold vs US Dollar
2,323.49
-0.18%
Brent Oil
84.835
-0.68%
Bitcoin
60,255.24
-2.19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Novartis Ag Basel Namen Akt (PK) (NVSEF) Share Price

NVSEF Novartis Ag Basel Namen Akt (PK)

104.00
1.31 (1.28%)
Last Updated: 19:15:29
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Novartis Ag Basel Namen Akt (PK) USOTC:NVSEF OTCMarkets Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   1.31 1.28 104.00 101.75 110.95 104.00 104.00 104 100 18:15:29   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 54.11B 14.85B 7.0131 14.83 220.28B
 Type  Size  Price  Time  Units 
  100 104.00 13:30:16 USD
 
Recent News
DateTimeSource
HeadlineMore NVSEF News
10/06/202421:30EDGAR2Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/06/202421:30EDGAR2Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
31/05/202411:00EDGAR2Form SD - Specialized disclosure report
16/05/202421:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
13/05/202421:30EDGAR2Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/05/202421:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/05/202421:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Period
Draw mode
Data Downloads for NVSEF

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Novartis Ag Basel Namen Akt (PK) Articles